SCOPUS 정보 검색 플랫폼

Blood

Volumn 118, Issue 3, 2011, Pages 483-

Could CR mean cure?

(2) Barlogie, Bart a Crowley, John a

a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; MELPHALAN; THALIDOMIDE;

ALLOGENEIC STEM CELL TRANSPLANTATION; EVENT FREE SURVIVAL; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE;

EID: 79960668064 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2011-05-350322 Document Type: Note

Times cited : (9)

References (8)

1
- 79960695172
- Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
- Martinez-Lopez J, Blade J, MateosMV,et al. Long-term prognostic significance of response in multiple myeloma after stem cell transplantation. Blood. 2011;118(3):529-534.
- (2011) Blood , vol.118 , Issue.3 , pp. 529-534
- Martinez-Lopez, J.¹ Blade, J.² Mateos, M.V.³

2
- 73349126431
- Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: Long-term analysis of the IFM 99-02 and 99-04 Trials
- Harousseau JL, Avet-Loiseau H, Attal M, et al. Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials. J Clin Oncol. 2009;27(34):5720-5726.
- (2009) J Clin Oncol , vol.27 , Issue.34 , pp. 5720-5726
- Harousseau, J.L.¹ Avet-Loiseau, H.² Attal, M.³

3
- 79955821742
- Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies
- Moreau P, Avet-Loiseau H, Harousseau JL, et al. Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies. J Clin Oncol. 2011;29(14):1898-1906.
- (2011) J Clin Oncol , vol.29 , Issue.14 , pp. 1898-1906
- Moreau, P.¹ Avet-Loiseau, H.² Harousseau, J.L.³

4
- 33947217497
- Avalidated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
- DOI 10.1182/blood-2006-07-038430
- Shaughnessy JD Jr, Zhan F, Burington BE, et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. 2007;109(6):2276-84. (Pubitemid 46425864)
- (2007) Blood , vol.109 , Issue.6 , pp. 2276-2284
- Shaughnessy Jr., J.D.¹ Zhan, F.² Burington, B.E.³ Huang, Y.⁴ Colla, S.⁵ Hanamura, I.⁶ Stewart, J.P.⁷ Kordsmeier, B.⁸ Randolph, C.⁹ Williams, D.R.¹⁰ Xiao, Y.¹¹ Xu, H.¹² Epstein, J.¹³ Anaissie, E.¹⁴ Krishna, S.G.¹⁵ Cottler-Fox, M.¹⁶ Hollmig, K.¹⁷ Mohiuddin, A.¹⁸ Pineda-Roman, M.¹⁹ Tricot, G.²⁰ more..

5
- 79960683987
- Myeloma
- Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, eds. New York, NY: McGraw-Hill Medical
- Van Rhee F, Anaissie E, Angtuaco E, et al. Myeloma. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, eds. Williams Hematology. New York, NY: McGraw-Hill Medical; 2010:1645-1681.
- (2010) Williams Hematology , pp. 1645-1681
- Van Rhee, F.¹ Anaissie, E.² Angtuaco, E.³

6
- 70349320472
- Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols
- Hoering A, Crowley J, Shaughnessy JD Jr, et al. Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols. Blood. 2009;114(7):1299-305.
- (2009) Blood , vol.114 , Issue.7 , pp. 1299-1305
- Hoering, A.¹ Crowley, J.² Shaughnessy Jr., J.D.³

7
- 34047195753
- Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
- DOI 10.1200/JCO.2006.08.5803
- Walker R, Barlogie B, Haessler J, et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol. 2007;25(9):1121-1128. (Pubitemid 46596765)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.9 , pp. 1121-1128
- Walker, R.¹ Barlogie, B.² Haessler, J.³ Tricot, G.⁴ Anaissie, E.⁵ Shaughnessy Jr., J.D.⁶ Epstein, J.⁷ Van Hemert, R.⁸ Erdem, E.⁹ Hoering, A.¹⁰ Crowley, J.¹¹ Ferris, E.¹² Hollmig, K.¹³ Van Rhee, F.¹⁴ Zangari, M.¹⁵ Pineda-Roman, M.¹⁶ Mohiuddin, A.¹⁷ Yaccoby, S.¹⁸ Sawyer, J.¹⁹ Angtuaco, E.J.²⁰ more..

8
- 70349231349
- F18-fluorode-oxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
- Bartel TB, Haessler J, Brown TL, et al. F18-fluorode-oxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009;114(10):2068-2076.
- (2009) Blood , vol.114 , Issue.10 , pp. 2068-2076
- Bartel, T.B.¹ Haessler, J.² Brown, T.L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.